These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 30768865)
1. Role of CD147 (EMMPRIN/Basigin) in Tissue Remodeling. Guindolet D; Gabison EE Anat Rec (Hoboken); 2020 Jun; 303(6):1584-1589. PubMed ID: 30768865 [TBL] [Abstract][Full Text] [Related]
2. The role of extracellular matrix metalloproteinase inducer glycosylation in regulating matrix metalloproteinases in periodontitis. Zhang Z; Yang X; Zhang H; Liu X; Pan S; Li C J Periodontal Res; 2018 Jun; 53(3):391-402. PubMed ID: 29315565 [TBL] [Abstract][Full Text] [Related]
3. CD147 and MMPs as key factors in physiological and pathological processes. Asgari R; Vaisi-Raygani A; Aleagha MSE; Mohammadi P; Bakhtiari M; Arghiani N Biomed Pharmacother; 2023 Jan; 157():113983. PubMed ID: 36370522 [TBL] [Abstract][Full Text] [Related]
4. Matrix Metalloproteinases and Their Inhibitors in Pulmonary Fibrosis: EMMPRIN/CD147 Comes into Play. Chuliá-Peris L; Carreres-Rey C; Gabasa M; Alcaraz J; Carretero J; Pereda J Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805895 [TBL] [Abstract][Full Text] [Related]
5. Role of emmprin/CD147 in tissue remodeling. Huet E; Gabison EE; Mourah S; Menashi S Connect Tissue Res; 2008; 49(3):175-9. PubMed ID: 18661337 [TBL] [Abstract][Full Text] [Related]
6. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Sameshima T; Nabeshima K; Toole BP; Yokogami K; Okada Y; Goya T; Koono M; Wakisaka S Cancer Lett; 2000 Sep; 157(2):177-84. PubMed ID: 10936678 [TBL] [Abstract][Full Text] [Related]
7. Structural insights on druggable hotspots in CD147: A bull's eye view. Kumar D; Vetrivel U; Parameswaran S; Subramanian KK Life Sci; 2019 May; 224():76-87. PubMed ID: 30904494 [TBL] [Abstract][Full Text] [Related]
8. Extracellular Matrix Metalloproteinase Inducer EMMPRIN (CD147) in Cardiovascular Disease. von Ungern-Sternberg SNI; Zernecke A; Seizer P Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29419744 [TBL] [Abstract][Full Text] [Related]
9. Direct epithelial-stromal interaction in corneal wound healing: Role of EMMPRIN/CD147 in MMPs induction and beyond. Gabison EE; Huet E; Baudouin C; Menashi S Prog Retin Eye Res; 2009 Jan; 28(1):19-33. PubMed ID: 19056510 [TBL] [Abstract][Full Text] [Related]
10. Early events of overused supraspinatus tendons involve matrix metalloproteinases and EMMPRIN/CD147 in the absence of inflammation. Attia M; Huet E; Gossard C; Menashi S; Tassoni MC; Martelly I Am J Sports Med; 2013 Apr; 41(4):908-17. PubMed ID: 23404084 [TBL] [Abstract][Full Text] [Related]
11. Dealing with the family: CD147 interactions with cyclophilins. Yurchenko V; Constant S; Bukrinsky M Immunology; 2006 Mar; 117(3):301-9. PubMed ID: 16476049 [TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix metalloproteinase inducer/CD147 promotes myofibroblast differentiation by inducing alpha-smooth muscle actin expression and collagen gel contraction: implications in tissue remodeling. Huet E; Vallée B; Szul D; Verrecchia F; Mourah S; Jester JV; Hoang-Xuan T; Menashi S; Gabison EE FASEB J; 2008 Apr; 22(4):1144-54. PubMed ID: 17965264 [TBL] [Abstract][Full Text] [Related]
13. Host CD147 blockade by small interfering RNAs suppresses growth of human colon cancer xenografts. Abraham D; Zins K; Sioud M; Lucas T; Aharinejad S Front Biosci; 2008 May; 13():5571-9. PubMed ID: 18508606 [TBL] [Abstract][Full Text] [Related]
14. The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literature. Xiong L; Edwards CK; Zhou L Int J Mol Sci; 2014 Sep; 15(10):17411-41. PubMed ID: 25268615 [TBL] [Abstract][Full Text] [Related]
15. The CD147-HYALURONAN Axis in Cancer. Toole BP Anat Rec (Hoboken); 2020 Jun; 303(6):1573-1583. PubMed ID: 31090215 [TBL] [Abstract][Full Text] [Related]
17. CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis. Xin X; Zeng X; Gu H; Li M; Tan H; Jin Z; Hua T; Shi R; Wang H Sci Rep; 2016 Sep; 6():32804. PubMed ID: 27608940 [TBL] [Abstract][Full Text] [Related]
18. CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer. Hao JL; Cozzi PJ; Khatri A; Power CA; Li Y Curr Cancer Drug Targets; 2010 May; 10(3):287-306. PubMed ID: 20370680 [TBL] [Abstract][Full Text] [Related]
19. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Gabison EE; Hoang-Xuan T; Mauviel A; Menashi S Biochimie; 2005; 87(3-4):361-8. PubMed ID: 15781323 [TBL] [Abstract][Full Text] [Related]
20. Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Nabeshima K; Iwasaki H; Koga K; Hojo H; Suzumiya J; Kikuchi M Pathol Int; 2006 Jul; 56(7):359-67. PubMed ID: 16792544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]